Annual General Meetings
The DCVMN’s Annual General Meetings bring together vaccine manufacturing leaders, experts from multilateral health organizations, and high-profiled researchers to dialogue equitable development of vaccines for protecting people against emerging diseases. DCVMN plays a central role in featuring panelist, exhibition presentations, and networking sessions for developing countries vaccine producers’ representatives.
Annual General Meeting 2024
October 16-18, 2024
São Paulo, Brazil
Below you will find the presentations shared by the speakers.
“D” stands for Day; “S” for Session. Not all speakers used or shared presentations.
Videos
Day 1
Inaugural session
Session 1: Global PPPR & Equitable Access to LICs
Session 2: Novel Technologies supporting Global Immunization
CEO Forum-Strategic direction of DCVMN Horizon 2050
CEO’S Report
Day 2
Session 2: Regulatory Harmonization and Clinical Development leading to Timely Access of Vaccines in LICs and LMICs
Session 3: Innovations in Financial Mechanisms: Influence & Impact on Universal Coverage
Session 4: Priority Vaccines: Polio, TB, Dengue, Malaria and Meningitis
Session 5: Private Sector Engagement to Boost Regional Manufacturing
Session 6: Novel Technologies
Session 7: Digital Technology and Impact of AI on Vaccine Manufacturing and Supply Chain
Announcement on latest initiatives by PAHO, Dr. Daniel Rodriguez, Director of Procurement-PAHO
Wrap-up by Mr. Tiago Rocca, Deputy Board Chair-DCVMN
Day 3
Special Session: mRNA Tech-Transfer Program by WHO/MPP
Session 9: Innovate: International Network for Vaccine Safety Surveillance Study
Session 10: Building Capacity: Vaccine Workforce Development Program
Session 11: Collaborating to Augment Vaccine Supply Chain Security
Session 12: Biodefence Strategies: An insurance against Biothreats
Session 14: Counter Vaccine Hesitancy and Build Confidence
Session 15: Partnerships Ecosystem: Gaps, Resources and Capabilities
Closing by Dr. Saulo Simoni Nacif and Mr. Rajinder Suri
Past Annual Meetings
